Active screening of group B Streptococci with reduced penicillin susceptibility and altered serotype distribution isolated from pregnant women in Kobe, Japan

Japanese Journal of Infectious Diseases

Volumn 66, Issue 2, 2013, Pages 158-160

  Kimura, Kouji ^a,b   Matsubara, Kousaku ^c   Yamamoto, Go ^c   Shibayama, Keigo ^b   Arakawa, Yoshichika ^a,b  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c NISHI KOBE MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFTIZOXIME; CLINDAMYCIN; ERYTHROMYCIN; MEROPENEM; OXACILLIN; PENICILLIN DERIVATIVE; PENICILLIN G;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; DISK DIFFUSION; FEMALE; HUMAN; INTRAPARTUM CARE; JAPAN; MEDICAL DECISION MAKING; PREGNANT WOMAN; SCREENING; SEROTYPE; STREPTOCOCCUS AGALACTIAE; VAGINA;

ANTI-BACTERIAL AGENTS; BETA-LACTAMS; FEMALE; HUMANS; INFANT, NEWBORN; JAPAN; MICROBIAL SENSITIVITY TESTS; PENICILLIN RESISTANCE; PREGNANCY; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; VAGINA;

EID: 84875283874     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: 10.7883/yoken.66.158     Document Type: Article

References (21)

1. Baker, C.J. (2000): Group B streptococcal infections. p. 222-237. In D.L. Stevens and E.L. Kaplan (ed.), Streptococcal Infections. Clinical Aspects, Microbiology, and Molecular Pathogenesis. Oxford University Press, Oxford.
2. Schuchat, A. (1999): Group B streptococcus. Lancet, 353, 51-56.
3. Schrag, S., Gorwitz, R., Fulz-Butts, K., et al. (2002): Prevention of perinatal group B streptococcal disease. Morbid. Mortal. Wkly. Rep. (RR-11), 51, 1-22.
4. Johri, A.K., Paoletti, L.C., Glaser, P., et al. (2006): Group B streptococcus: global incidence and vaccine development. Nature Rev. Microbiol., 4, 932-942.
5. Clinical and Laboratory Standards Institute (2006): Performance Standards for Antimicrobial Susceptibility Testing; 16th informational supplement, M100-S16. CLSI. Wayne, Pa.
6. Kimura, K., Suzuki, S., Wachino, J., et al. (2008): First molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrob. Agents Chemother., 52, 2890-2897.
7. Nagano, N., Nagano, Y., Kimura, K., et al. (2008): Genetic heterogeneity in pbp genes among clinically isolated group B streptococci with reduced penicillin susceptibility. Antimicrob. Agents Chemother., 52, 4258-4267.
8. Dahesh, S., Hensler, M.E., Van Sorge, N.M., et al. (2008): Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to β-lactam antibiotics. Antimicrob. Agents Chemother., 52, 2915-2918.
9. Gaudreau, C., Lecours, R., Ismail, J., et al. (2009): Prosthetic hip joint infection with a Streptococcus agalactiae isolate not susceptible to penicillin G and ceftriaxone. J. Antimicrob. Chemother., 65, 594-595.
10. Longtin, J., Vermeiren, C., Shahinas, D., et al. (2011): Novel mutations in a patient isolate of Streptococcus agalactiae with reduced penicillin susceptibility emerging after long-term oral suppressive therapy. Antimicrob. Agents Chemother., 55, 2983-2985.
11. Kimura, K., Nagano, N., Nagano, Y., et al. (2011): Predominance of sequence type 1 group with serotype VI among group B streptococci with reduced penicillin susceptibility identified in Japan. J. Antimicrob. Chemother., 66, 2460-2464.
12. Murayama, S.Y., Seki, C., Sakata, H., et al. (2009): Capsular type and antibiotic resistance in Streptococcus agalactiae isolates from patients, ranging from newborns to the elderly, with invasive infections. Antimicrob. Agents Chemother., 53, 2650-2653.
13. Nagano, N., Kimura, K., Nagano, Y., et al. (2009): Molecular characterization of group B streptococci with reduced penicillin susceptibility recurrently isolated from sacral decubitus ulcer. J. Antimicrob. Chemother., 64, 1326-1328.
14. Nagano, N., Nagano, Y., Toyama, M., et al. (2012): Nosocomial spread of multidrug-resistant group B streptococci with reduced penicillin susceptibility belonging to clonal complex 1. J. Antimicrob. Chemother., 67, 849-856.
15. Lachenauer, C.S., Kasper, D.L., Shimada, J., et al. (1999): Serotype VI and VIII predominate among group B streptococci isolated from pregnant Japanese women. J. Infect. Dis., 179, 1030-1033.
16. Matsubara, K., Nishiyama, Y., Katayama, K., et al. (2001): Change of antimicrobial susceptibility of group B streptococci over 15 years in Japan. J. Antimicrob. Chemother., 48, 579-582.
17. Terakubo, S., Ichiman, Y., Takemura, H., et al. (2003): Serotypes and antibody levels of group B streptococci in pregnant women. J. Jpn. Assoc. Inect. Dis., 77, 121-126 (in Japanese).
18. Matsubara, K., Sugiyama, M., Hoshina, K., et al. (2000): Early onset neonatal sepsis caused by serotype VIII group B streptococci. Pediatr. Infect. Dis., 19, 359-360.
19. Matsubara, K., Mikamo, H., Numa, M., et al. (2006): Three fatal cases of invasive serotype VI group B streptococcal infection. J. Infect., 53, e139-142.
20. Kimura, K., Wachino, J., Kurokawa, H., et al. (2009): Practical disk diffusion test for detecting group B streptococcus with reduced penicillin susceptibility. J. Clin. Microbiol., 47, 4154-4157.
21. Poyart, C., Tazi, A., Reglier-Poupet, H., et al. (2007): Multiplex PCR assay for rapid and accurate capsular typing of group B streptococci. J. Clin. Microbiol., 45, 1985-1988.